Sugarloaf Wealth Management, LLC - INVIVO THERAPEUTICS HLDGS CO ownership

Back to all holdings Add to watchlist

INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M506. A total of 17 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Sugarloaf Wealth Management, LLC ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2022$0–10.0%0.00%–
Q4 2021$0–10.0%0.00%–
Q3 2021$0–10.0%0.00%–
Q2 2021$0–10.0%0.00%–
Q1 2021$0–10.0%0.00%–
Q4 2020$0–10.0%0.00%–
Q3 2020$0–10.0%0.00%–
Q2 2020$0–10.0%0.00%–
Q1 2020$0–1–0.00%–
 Download
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q4 2020
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 81,491$116,0000.01%
NewSquare Capital LLC 62$00.00%
UBS Group AG 6,303$9,0000.00%
Sugarloaf Wealth Management, LLC 1$00.00%
OSAIC HOLDINGS, INC. 32$00.00%
Jacobi Capital Management LLC 1$00.00%
BANK OF AMERICA CORP /DE/ 39$00.00%
FLAGSHIP HARBOR ADVISORS, LLC 1$00.00%
WELLS FARGO & COMPANY/MN 32$00.00%
NORTHERN TRUST CORP 12,751$18,0000.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders